Search Results - "Cardiac failure review"
-
1
Global Public Health Burden of Heart Failure: An Updated Review
Published in Cardiac failure review (01-01-2023)“…Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64 million people globally. Although the incidence of HF has…”
Get full text
Journal Article -
2
Right Ventricular Failure: Pathophysiology, Diagnosis and Treatment
Published in Cardiac failure review (04-11-2019)“…The prognostic significance of the right ventricle (RV) has recently been recognised in several conditions, primarily those involving the left ventricle, the…”
Get full text
Journal Article -
3
The Future of Telemedicine in the Management of Heart Failure Patients
Published in Cardiac failure review (28-05-2021)“…Telemedicine (TM) is potentially a way of escalating heart failure (HF) multidisciplinary integrated care. Despite the initial efforts to implement TM in HF…”
Get full text
Journal Article -
4
Biomarkers in Routine Heart Failure Clinical Care
Published in Cardiac failure review (01-02-2019)“…Heart failure is a clinical condition with complex pathophysiology that involves many different processes. Diagnosis is often difficult in patients presenting…”
Get full text
Journal Article -
5
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Published in Cardiac failure review (07-08-2020)“…Levosimendan was first approved for clinic use in 2000, when authorisation was granted by Swedish regulatory authorities for the haemodynamic stabilisation of…”
Get full text
Journal Article -
6
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
Published in Cardiac failure review (01-01-2022)“…Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting the exaggerated fibrotic response and possibly through additional…”
Get full text
Journal Article -
7
Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction
Published in Cardiac failure review (01-01-2022)“…Heart failure (HF) with preserved ejection (HFpEF) constitutes a large and growing proportion of patients with HF around the world, and is now responsible for…”
Get full text
Journal Article -
8
In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
Published in Cardiac failure review (01-01-2022)“…Implementation of guideline-directed medical therapy for patients with heart failure is suboptimal. The use of guideline-directed medical therapy improves…”
Get full text
Journal Article -
9
Unequitable Heart Failure Therapy for Black, Hispanic and American-Indian Patients
Published in Cardiac failure review (01-01-2022)“…Despite the high prevalence of heart failure among Black and Hispanic populations, patients of colour are frequently under-prescribed guideline-directed…”
Get full text
Journal Article -
10
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
Published in Cardiac failure review (2021)“…There are gaps in the use of therapies that save lives and improve quality of life for patients with heart failure with reduced ejection fraction, both in the…”
Get full text
Journal Article -
11
Biomarkers in Heart Failure with Preserved Ejection Fraction
Published in Cardiac failure review (01-01-2022)“…Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder developing from multiple aetiologies with overlapping pathophysiological…”
Get full text
Journal Article -
12
Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis
Published in Cardiac failure review (01-01-2022)“…Heart failure with preserved ejection fraction (HFpEF) currently accounts for approximately half of all new heart failure cases in the community. HFpEF is…”
Get full text
Journal Article -
13
Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
Published in Cardiac failure review (01-05-2019)“…The main focus of cardio-oncology has been the prevention and treatment of the cardiac toxicity of chemotherapy and radiotherapy. Furthermore, several targeted…”
Get full text
Journal Article -
14
Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction
Published in Cardiac failure review (01-01-2023)“…Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with preserved ejection fraction (HFpEF) has traditionally received less…”
Get full text
Journal Article -
15
Glucagon-like Peptide-1 Receptor Agonists in the Context of Pathophysiology of Diverse Heart Failure with Preserved Ejection Fraction Phenotypes: Potential Benefits and Mechanisms of Action
Published in Cardiac failure review (16-10-2024)“…This review examines the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on different heart failure phenotypes with preserved ejection fraction…”
Get full text
Journal Article -
16
Heart Failure Nurses within the Primary Care Setting
Published in Cardiac failure review (01-01-2024)“…Cardiology services within primary care often focus on disease prevention, early identification of illness and prompt referral for diagnosis and specialist…”
Get full text
Journal Article -
17
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
Published in Cardiac failure review (01-01-2023)“…Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome resulting from the interaction between cardiac diseases, comorbidities and…”
Get full text
Journal Article -
18
The Impact of Frailty and Comorbidities on Heart Failure Outcomes
Published in Cardiac failure review (01-01-2022)“…Frailty is a multisystemic process leading to reduction of physiological reserve and a reduction in physical activity. Heart failure (HF) is recognised as a…”
Get full text
Journal Article -
19
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice
Published in Cardiac failure review (13-11-2020)“…Heart failure is a shared chronic phase of many cardiac diseases and its prevalence is on the rise globally. Previous large-scale cardiovascular outcomes…”
Get full text
Journal Article -
20
Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
Published in Cardiac failure review (01-01-2024)“…There is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life…”
Get full text
Journal Article